Simpson Thacher Represents Underwriters in Syneos Health’s Secondary Offering of 7 Million Shares of Common Stock
09.21.20
This is only gets display when printing
Simpson Thacher represented Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC (the “Underwriters”) in connection with the secondary offering by affiliates of Thomas H. Lee Partners, L.P. and Advent International Corporation of an aggregate of 7,000,000 shares of Syneos Health, Inc.’s (“Syneos Health”) common stock. Syneos Health repurchased from the Underwriters 506,244 shares of common stock being sold by the selling stockholders.
Syneos Health is a leading global biopharmaceutical solutions organization providing a full suite of clinical and commercial services to customers in the biopharmaceutical, biotechnology and medical device industries. Syneos Health offers both stand-alone and integrated biopharmaceutical product development solutions through its Contract Research Organization and Contract Commercial Organization, ranging from Early Phase (Phase I) clinical trials to the full commercialization of biopharmaceutical products, with the goal of increasing the likelihood of regulatory approval and commercial success.
The Simpson Thacher team included Roxane Reardon, Sean Dougherty, Ashley Yoon, Gianna Ceophas, Tommy Garber and Alexander Porro (Capital Markets); Marcy Geller and Sarah Katz (Tax); Vanessa Burrows (Healthcare); Lori Lesser and Bobbie Burrows (IP); and Jennie Getsin (FINRA).